Skip to content

Clinical trials

Endocrine System Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20141
20163
20172
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Unknown status2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
KU Leuven2
Belgian Gynaecological Oncology Group1
Celgene1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Eli Lilly and Company1
Fractyl Health Inc.1
Hoffmann-La Roche1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Sumitomo Pharma America, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases11
Neoplasms7
Endocrine Gland Neoplasms6
Adenocarcinoma4
Diabetes Mellitus4
Digestive System Neoplasms4
Neoplasms by Site4
Diabetes Mellitus, Type 23
Digestive System Diseases3
Genital Diseases, Female3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.